Indicator,S.No.,Parameters,Type,District - _Delhi,District - Central,District - East,District - New Delhi,District - North,District - North East,District - North West,District - Shahdara,District - South,District - South East,District - South West,District - West
M1 [Ante Natal Care Services ANC],1.1,Total number of pregnant women Registered for ANC,TOTAL,576307,67954,30019,60452,55813,31854,61233,87437,25051,34609,23478,98407
M1 [Ante Natal Care Services ANC],1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,179876,20228,8087,11900,14148,11688,23238,15517,9381,16740,11267,37682
M1 [Ante Natal Care Services ANC],1.2,Number of Pregnant women registered under JSY,TOTAL,15951,2722,642,941,1200,755,2341,1210,308,890,1202,3740
M1 [Ante Natal Care Services ANC],1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,334599,43683,15169,38266,28127,19212,47632,35778,14251,18595,16841,57045
M1 [Ante Natal Care Services ANC],1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,173491,19039,9497,14399,15808,12368,22709,19796,9400,13645,11878,24952
M1 [Ante Natal Care Services ANC],1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,155882,18518,9693,11785,15210,11659,19924,15729,8882,12652,11166,20664
M1 [Ante Natal Care Services ANC],1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,317128,29476,13280,40126,31653,16457,41201,33501,12722,13918,15952,68842
M1 [Ante Natal Care Services ANC],1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,11392,751,337,1482,614,229,1491,780,791,269,1595,3053
M1 [Ante Natal Care Services ANC],1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,891,261,9,177,40,8,106,101,21,16,11,141
M1 [Ante Natal Care Services ANC],1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,175170,19016,8736,20746,18045,10703,33103,14681,4968,11079,15120,18973
M1 [Ante Natal Care Services ANC],1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,9750,456,237,1024,735,182,2022,1745,210,197,1342,1600
M1 [Ante Natal Care Services ANC],1.8,Number of pregnancy test kits used at SC level,TOTAL,15048,551,564,1278,697,1147,389,945,4357,4023,252,845
M2 [Deliveries],2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,830,0,121,6,5,0,42,0,273,344,3,36
M2 [Deliveries],2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,9266,603,360,258,2015,1467,877,382,835,733,542,1194
M2 [Deliveries],2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,10096,603,481,264,2020,1467,919,382,1108,1077,545,1230
M2 [Deliveries],2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,4960,432,280,153,957,485,250,301,501,506,311,784
M2 [Deliveries],2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,37,6,0,15,0,1,1,0,5,2,7,0
M2 [Deliveries],2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,125181,20172,5167,26015,4464,3598,19456,20738,3293,2283,6079,13916
M2 [Deliveries],2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,58853,10998,2862,18252,1702,2712,2875,3493,2028,1306,4513,8112
M2 [Deliveries],2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,6226,1079,319,511,861,100,1091,471,210,129,781,674
M2 [Deliveries],2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2092,457,281,339,1,23,60,43,173,85,510,120
M2 [Deliveries],2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M2 [Deliveries],2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,25012,5189,1991,113,497,115,4338,1877,2646,3029,1131,4086
M2 [Deliveries],2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M2 [Deliveries],2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M2 [Deliveries],2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,18,0,NA,18,NA,0,0,NA,NA,0,NA,0
M3 [Number of Caesarean C-Section deliveries performed at],3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,28263,4922,985,6601,263,358,4338,4850,1047,284,1061,3554
M3 [Number of Caesarean C-Section deliveries performed at],3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M3 [Number of Caesarean C-Section deliveries performed at],3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,28281,4922,985,6619,263,358,4338,4850,1047,284,1061,3554
M3 [Number of Caesarean C-Section deliveries performed at],3.2,No. of C-section deliveries performed at Private facilities,TOTAL,14910,3155,1285,64,164,80,2822,1185,1271,1588,703,2593
M4 [Pregnancy outcome & weight of new-born],4.1.1.a,Number of male live births,TOTAL,83731,13620,3989,13663,3580,2628,12880,12105,3745,3383,4105,10033
M4 [Pregnancy outcome & weight of new-born],4.1.1.b,Number of female live births,TOTAL,75190,12100,3561,12371,3351,2533,11590,10619,3337,3054,3600,9074
M4 [Pregnancy outcome & weight of new-born],4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,158921,25720,7550,26034,6931,5161,24470,22724,7082,6437,7705,19107
M4 [Pregnancy outcome & weight of new-born],4.1.2,Number of still births,TOTAL,3105,577,125,693,81,34,516,511,96,51,71,350
M4 [Pregnancy outcome & weight of new-born],4.1.3,Number of Abortions (spontaneous or induced),TOTAL,21158,3284,2170,1682,1259,322,3047,2093,1531,1394,1003,3373
M4 [Pregnancy outcome & weight of new-born],4.2.1,Number of Newborns weighed at birth,TOTAL,151046,24336,7307,24622,6327,4448,23903,22610,6750,5711,7558,17474
M4 [Pregnancy outcome & weight of new-born],4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,33106,5588,1483,3863,1215,908,5578,7077,1056,651,1278,4409
M4 [Pregnancy outcome & weight of new-born],4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,117051,16946,4582,20934,6111,4187,17688,18436,5359,4262,5873,12673
M5 [Complicated pregnanices],5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6,0,0,0,0,0,0,0,6,0,0,0
M5 [Complicated pregnanices],5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,419,0,6,0,10,160,23,137,NA,82,NA,1
M5 [Complicated pregnanices],5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,41805,10019,2480,5707,3595,182,3846,7174,2658,373,1342,4429
M5 [Complicated pregnanices],5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M5 [Complicated pregnanices],5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,42230,10019,2486,5707,3605,342,3869,7311,2664,455,1342,4430
M5 [Complicated pregnanices],5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,5329,896,161,0,214,68,542,761,1047,1142,217,281
M5 [Complicated pregnanices],5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,32004,7116,2639,3636,640,290,3852,5299,1892,1537,1283,3820
M5 [Complicated pregnanices],5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3237,328,13,565,127,162,226,696,222,90,93,715
M5 [Complicated pregnanices],5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,30105,9986,2031,2457,856,308,3565,3219,2190,1533,844,3116
M5 [Complicated pregnanices],5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10106,1343,964,1643,317,32,1483,1861,212,82,250,1919
M6 [Post - Natal Care],6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,139500,20367,6104,25085,6208,4706,21768,20258,6148,5554,7485,15817
M6 [Post - Natal Care],6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,100471,13625,4174,8923,5519,4198,13788,13322,2642,4895,9849,19536
M6 [Post - Natal Care],6.3,PNC maternal complications attended,TOTAL,3747,249,869,400,167,0,889,229,39,199,258,448
M7 [Medical Termination of Pregnancy (MTP)],7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3689,668,43,501,134,36,654,344,385,200,161,563
M7 [Medical Termination of Pregnancy (MTP)],7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,526,66,5,134,5,0,49,89,138,0,7,33
M7 [Medical Termination of Pregnancy (MTP)],7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4215,734,48,635,139,36,703,433,523,200,168,596
M7 [Medical Termination of Pregnancy (MTP)],7.2,Number of MTPs conducted at Private Facilities,TOTAL,7453,1096,1455,61,206,16,1080,627,466,934,392,1120
M8 [RTI/STI Cases],8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,20477,3210,1006,4018,1270,765,1481,791,1492,1796,1648,3000
M8 [RTI/STI Cases],8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,105510,12867,6485,14646,6631,7871,9685,6488,3648,5574,5709,25906
M8 [RTI/STI Cases],8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,125987,16077,7491,18664,7901,8636,11166,7279,5140,7370,7357,28906
M8 [RTI/STI Cases],8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,331,0,2,0,0,0,2,0,31,21,6,269
M9 [Family Planning],9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,NA,0,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,953,678,8,92,5,8,18,15,7,1,79,42
M9 [Family Planning],9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,953,678,8,92,5,8,18,15,7,1,79,42
M9 [Family Planning],9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,27,25,1,0,0,NA,0,0,1,0,0,0
M9 [Family Planning],9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,NA,0,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,3242,1053,14,519,46,11,439,193,343,39,136,449
M9 [Family Planning],9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,3242,1053,14,519,46,11,439,193,343,39,136,449
M9 [Family Planning],9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,1122,31,33,81,5,NA,547,253,13,132,2,25
M9 [Family Planning],9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0,0,NA,0,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,1136,137,64,585,18,2,107,77,25,3,62,56
M9 [Family Planning],9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1136,137,64,585,18,2,107,77,25,3,62,56
M9 [Family Planning],9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,96,13,8,0,3,NA,24,0,17,18,0,13
M9 [Family Planning],9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,7,0,NA,7,NA,0,0,NA,NA,0,NA,0
M9 [Family Planning],9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,2856,323,0,474,20,35,787,560,102,25,73,457
M9 [Family Planning],9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2863,323,0,481,20,35,787,560,102,25,73,457
M9 [Family Planning],9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,208,41,10,0,10,NA,19,4,5,43,5,71
M9 [Family Planning],9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,8,8,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,14242,2221,955,779,869,1237,1360,835,1204,1362,1460,1960
M9 [Family Planning],9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4883,628,378,263,392,706,469,475,NA,540,80,952
M9 [Family Planning],9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,29674,4612,1535,4411,2279,753,5293,3504,1157,642,993,4495
M9 [Family Planning],9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M9 [Family Planning],9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,48807,7469,2868,5453,3540,2696,7122,4814,2361,2544,2533,7407
M9 [Family Planning],9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,25911,4031,1562,3708,1926,957,4281,3045,664,621,714,4402
M9 [Family Planning],9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,2211,318,149,108,143,20,353,248,143,308,98,323
M9 [Family Planning],9.06,Number of IUCD removals,TOTAL,7860,1008,554,676,551,483,966,603,543,634,655,1187
M9 [Family Planning],9.07,Number of Oral Pills cycles distributed,TOTAL,117011,12737,8590,8886,11035,8265,13396,11469,7410,14055,8112,13056
M9 [Family Planning],9.08,Number of Condom pieces distributed,TOTAL,4187255,494395,150472,302840,427135,229254,686806,226392,391365,477399,327344,473853
M9 [Family Planning],9.09,Number of Centchroman (weekly) pills given,TOTAL,115,63,0,0,0,0,0,0,33,0,8,11
M9 [Family Planning],9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,9585,652,866,572,1181,910,1101,693,1128,791,555,1136
M9 [Family Planning],9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.1.b,Number of cases of complications following female sterilization,TOTAL,12,0,0,0,0,0,0,9,0,0,2,1
M9 [Family Planning],9.11.2.a,Number of failures following male sterilization,TOTAL,1,0,0,0,0,0,0,0,0,0,0,1
M9 [Family Planning],9.11.2.b,Number of failures following female sterilization,TOTAL,30,9,0,4,1,0,7,6,0,0,0,3
M9 [Family Planning],9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M9 [Family Planning],9.12,Number of Institutions having NSV trained doctors,TOTAL,379,40,30,49,21,4,87,49,37,19,16,27
M10 [CHILD IMMUNIZATION],10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,178208,23311,9346,28422,10495,8075,26069,24080,7964,9532,8934,21980
M10 [CHILD IMMUNIZATION],10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,10066,1460,559,112,417,570,1481,569,1041,1731,245,1881
M10 [CHILD IMMUNIZATION],10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,8609,1302,506,106,353,530,1041,409,920,1570,245,1627
M10 [CHILD IMMUNIZATION],10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,8183,1356,466,117,338,467,1035,437,686,1489,228,1564
M10 [CHILD IMMUNIZATION],10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,163385,15901,10674,9327,15930,16067,21082,14737,9730,15642,12602,21693
M10 [CHILD IMMUNIZATION],10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,159861,15130,11318,8241,15884,15578,21111,13677,9825,15553,12350,21194
M10 [CHILD IMMUNIZATION],10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,160867,15105,11064,8240,16214,15299,21116,13604,9944,15743,12680,21858
M10 [CHILD IMMUNIZATION],10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,141600,20880,7184,25539,5423,4384,21041,21700,6057,4972,6939,17481
M10 [CHILD IMMUNIZATION],10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,169492,17263,11383,9264,16081,16328,21636,15182,9012,17080,12808,23455
M10 [CHILD IMMUNIZATION],10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,164962,16404,11754,8147,15949,15879,21236,13992,9439,16829,12614,22719
M10 [CHILD IMMUNIZATION],10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,166090,16368,11619,8226,16188,15493,21338,13826,9660,17082,12927,23363
M10 [CHILD IMMUNIZATION],10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,132975,18290,7000,25380,5127,3860,20500,20994,5319,4713,6807,14985
M10 [CHILD IMMUNIZATION],10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,10568,1830,898,86,155,936,1414,699,659,1389,293,2209
M10 [CHILD IMMUNIZATION],10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7355,1245,732,110,128,347,1032,399,748,1202,233,1179
M10 [CHILD IMMUNIZATION],10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,6805,1469,610,131,172,308,832,349,671,1002,243,1018
M10 [CHILD IMMUNIZATION],10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,190490,18498,13220,9564,18863,17699,24358,15488,11966,19690,14691,26453
M10 [CHILD IMMUNIZATION],10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,9959,1163,629,400,527,1403,1736,715,568,1039,494,1285
M10 [CHILD IMMUNIZATION],10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,6,0,0,0,6,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,98354,9396,6879,5032,9912,9047,12787,7702,5970,9735,7887,14007
M10 [CHILD IMMUNIZATION],10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,85048,8137,5967,4230,8476,7999,11120,6845,5219,8396,6605,12054
M10 [CHILD IMMUNIZATION],10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,183402,17533,12846,9262,18388,17046,23907,14547,11189,18131,14492,26061
M10 [CHILD IMMUNIZATION],10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,184661,17573,13450,9231,18218,17519,24011,14788,11405,17398,14953,26115
M10 [CHILD IMMUNIZATION],10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,183603,17542,13408,9232,18101,17414,23614,14671,11595,17312,14946,25768
M10 [CHILD IMMUNIZATION],10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,191644,18796,13839,9929,18943,16019,24162,16997,12519,20259,15223,24958
M10 [CHILD IMMUNIZATION],10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,27449,2808,893,1558,3034,3275,3877,2604,1283,1033,1974,5110
M10 [CHILD IMMUNIZATION],10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,23323,2421,759,1079,2492,3089,3451,2103,1161,906,1628,4234
M10 [CHILD IMMUNIZATION],10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,50772,5229,1652,2637,5526,6364,7328,4707,2444,1939,3602,9344
M10 [CHILD IMMUNIZATION],10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,90066,9792,6710,4885,7940,6732,11055,6734,6028,8896,8005,13289
M10 [CHILD IMMUNIZATION],10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,25916,3067,2223,2143,1742,1843,2809,1782,2150,2911,2118,3128
M10 [CHILD IMMUNIZATION],10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,16952,2736,1283,1390,1543,955,1901,1698,1192,1508,1505,1241
M10 [CHILD IMMUNIZATION],10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,8,0,6,0,0,0,2,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M10 [CHILD IMMUNIZATION],10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,14,4,2,0,0,0,3,1,1,3,0,0
M10 [CHILD IMMUNIZATION],10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,73466,9658,5798,4202,7254,5204,10021,4743,4194,7322,4825,10245
M10 [CHILD IMMUNIZATION],10.4.2,Number of Immunisation sessions held during the month,TOTAL,71473,9472,5646,3928,7024,5114,9758,4617,4136,7132,4664,9982
M10 [CHILD IMMUNIZATION],10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,38889,2112,3703,1672,4054,4054,4884,2258,2200,4566,3669,5717
M10 [CHILD IMMUNIZATION],10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4,0,0,0,0,0,0,0,0,4,0,0
M11 [Number of Vitamin A doses],11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,137683,11044,12839,5279,11246,14430,14663,11222,9818,14204,14016,18922
M11 [Number of Vitamin A doses],11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,97186,6317,11745,2315,13206,8362,9784,7681,5905,10588,6429,14854
M11 [Number of Vitamin A doses],11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,40924,2229,5272,1019,4890,4592,4523,2835,2192,5547,2615,5210
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,3,0,0,2,0,0,1,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,3,0,0,3,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,6,0,0,6,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,481,42,46,64,49,11,59,101,66,24,4,15
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,70721,5538,6316,7735,20640,1154,6857,3538,2097,4208,2380,10258
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,878,136,64,268,181,0,101,49,26,24,19,10
M12 [Number of cases of Childhood Diseases reported during the month0-5 years:],12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,12332,1245,1217,3511,656,0,1353,560,1178,295,298,2019
M13 [Blindness Control Programme],13.1,Number of Patients operated for cataract,TOTAL,30258,14870,611,4027,461,236,2745,1227,374,1583,98,4026
M13 [Blindness Control Programme],13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,28634,14680,275,3977,254,236,2318,930,369,1523,61,4011
M13 [Blindness Control Programme],13.3,Number of School children detected with Refractive errors,TOTAL,14372,601,209,0,1133,372,1863,2394,1555,506,613,5126
M13 [Blindness Control Programme],13.4,Number of children provided free glasses,TOTAL,1527,0,0,0,0,0,451,0,0,0,0,1076
M13 [Blindness Control Programme],13.5,Number of eyes collected through eye donation,TOTAL,961,753,0,61,0,0,0,20,0,0,0,127
M13 [Blindness Control Programme],13.6,Number of eyes utilised for corneal transplant,TOTAL,579,421,0,25,0,0,0,6,0,0,0,127
M14 [Patient Services],14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,271,39,15,28,21,27,60,36,6,4,7,28
M14 [Patient Services],14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA
M14 [Patient Services],14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2671,40,33,0,0,15,1846,15,268,351,41,62
M14 [Patient Services],14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,236,28,26,7,21,28,42,35,NA,7,14,28
M14 [Patient Services],14.05,Number of RKS meetings held during the month,TOTAL,45,5,2,0,3,6,15,2,0,2,5,5
M14 [Patient Services],14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1226,100,239,185,36,28,147,78,61,77,185,90
M14 [Patient Services],14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,30189,2030,3712,9296,692,829,3581,1606,766,1660,1851,4166
M14 [Patient Services],14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,403,63,32,35,18,2,64,49,43,38,24,35
M14 [Patient Services],14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1186,219,102,223,15,0,353,38,30,92,24,90
M14 [Patient Services],14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,179773,33980,12747,45507,6092,1805,28310,16399,5216,9992,6342,13383
M14 [Patient Services],14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,376525,114960,19791,48115,4444,2985,59142,39253,12716,26129,11146,37844
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,140294,18801,8368,46399,4615,1595,22248,12228,4128,5963,5366,10583
M14 [Patient Services],14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,478538,99037,29600,63736,11414,7418,80536,63320,16889,29173,19584,57831
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,320067,52781,21115,91906,10707,3400,50558,28627,9344,15955,11708,23966
M14 [Patient Services],14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,855063,213997,49391,111851,15858,10403,139678,102573,29605,55302,30730,95675
M14 [Patient Services],14.10.2.a,Number of death cases of Inpatient males,TOTAL,15816,5145,1294,3479,307,11,2430,746,327,386,133,1558
M14 [Patient Services],14.10.2.b,Number of death cases of Inpatient females,TOTAL,9348,2657,768,2042,117,22,1567,553,193,246,76,1107
M14 [Patient Services],14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,25164,7802,2062,5521,424,33,3997,1299,520,632,209,2665
M14 [Patient Services],14.11,In-Patient Head Count at midnight,TOTAL,2995888,468347,207990,819196,89758,25502,406902,229240,125717,252812,80823,289601
M14 [Patient Services],14.12.1,OPD attendance (All),TOTAL,38113597,5323189,2228557,5765057,2292447,1698899,5178920,3953428,1696155,2423976,2529129,5023840
M14 [Patient Services],14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,198810,45881,13644,35361,2229,1520,27123,12800,12543,19165,3854,24690
M14 [Patient Services],14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,4277,841,366,575,160,30,865,256,328,319,240,297
M14 [Patient Services],14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,0,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,389639,28383,27240,57634,21077,7790,73916,17535,3206,13190,4297,135371
M14 [Patient Services],14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,0,0,NA,NA,NA,NA,NA,0,NA,NA,NA,NA
M14 [Patient Services],14.14.a,Number of patients given AYUSH treatment,TOTAL,1190758,177128,140784,133254,111475,2562,111657,155047,27714,125536,56896,148705
M14 [Patient Services],14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,339316,85670,7902,87851,18524,1148,38508,11543,6260,17847,18516,45547
M14 [Patient Services],14.14.c,Number of Adolescents counselled,TOTAL,44953,10205,3091,2673,5044,2343,8872,1721,280,1814,4773,4137
M15 [Laboratory Testing],15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,1049210,1030833,NA,NA,NA,NA,NA,18377,NA,NA,NA,NA
M15 [Laboratory Testing],15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3876403,1354194,215932,458267,121904,61479,449428,310564,254072,118878,151236,380449
M15 [Laboratory Testing],15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,88006,15319,4701,9958,3598,2127,11419,12626,2768,1402,3331,20757
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,1. Number tested,182483,33864,18099,38925,5819,4309,24925,12012,18783,4504,5417,15826
M15 [Laboratory Testing],15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1890,231,92,577,59,78,368,135,105,27,48,170
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,115139,15343,9265,19404,5463,4714,18341,9758,10589,4311,4621,13330
M15 [Laboratory Testing],15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,737,58,56,255,14,12,146,37,35,10,19,95
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,168902,24330,10822,17951,14943,13264,25744,18217,8110,5867,14034,15620
M15 [Laboratory Testing],15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,718,30,11,70,12,141,86,298,18,2,9,41
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,466524,73537,38186,76280,26225,22287,69010,39987,37482,14682,24072,44776
M15 [Laboratory Testing],15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3345,319,159,902,85,231,600,470,158,39,76,306
M15 [Laboratory Testing],15.2,Number of Widal tests conducted,Number tested,231878,22785,15857,24654,17966,5684,35873,24616,11508,11182,18304,43449
M15 [Laboratory Testing],15.3.a,Number of VDRL tests conducted on males,Number tested,38105,3148,9193,11530,1458,242,1606,1620,4240,1334,782,2952
M15 [Laboratory Testing],15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,40250,3234,2065,12445,2376,1599,3387,1149,1796,1293,1349,9557
M15 [Laboratory Testing],15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,158613,17025,9056,18547,11167,9697,31258,13675,7421,6900,16165,17702
M15 [Laboratory Testing],15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,236968,23407,20314,42522,15001,11538,36251,16444,13457,9527,18296,30211
M15 [Laboratory Testing],15.4.1,Number of blood smears examined for Malaria,TOTAL,543422,25652,14983,30115,8580,4466,47496,44961,286222,14294,24100,42553
M15 [Laboratory Testing],15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3345,127,280,326,71,41,511,463,623,321,199,383
M15 [Laboratory Testing],15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,684,6,20,20,0,4,369,3,15,240,4,3
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,258010,18110,17920,25040,24250,16110,25560,9110,33670,22770,26570,38900
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,2. Stocks Received,298690,39000,20500,16000,23020,16500,38130,20600,22940,27000,30500,44500
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,3. Unusable Stock,22180,2560,1220,0,0,0,18400,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,4. Stock Distributed,288557,31530,23240,17280,17810,20827,38770,21730,23800,30020,27640,35910
M16 [Stock Position (During the month)],16.1.1,Stock position of DPT vaccines,5. Total Stock,245963,23020,13960,23760,29460,11783,6520,7980,32810,19750,29430,47490
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,324550,27770,10230,34130,16780,27650,30130,20210,42740,46280,33240,35390
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,2. Stocks Received,443660,44700,28440,26400,32640,38960,75360,40730,26110,42960,29280,58080
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,12870,490,0,0,0,0,12380,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,421710,42740,30380,25790,26980,31220,69040,41770,26600,43040,30400,53750
M16 [Stock Position (During the month)],16.1.1A,Stock Position of Pentavalent,5. Total Stock,333630,29240,8290,34740,22440,35390,24070,19170,42250,46200,32120,39720
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,442700,69620,23100,38740,19030,24890,24120,17880,58820,51460,44440,70600
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,2. Stocks Received,749020,94100,54040,73780,41000,42000,87080,60000,56000,64000,43000,134020
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,3. Unusable Stock,11020,1760,0,0,0,0,9260,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,4. Stock Distributed,750430,114120,53620,77520,32290,33230,77380,63760,48260,58610,53140,138500
M16 [Stock Position (During the month)],16.1.2,Stock position of OPV vaccines,5. Total Stock,430270,47840,23520,35000,27740,33660,24560,14120,66560,56850,34300,66120
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,329280,54340,10510,39980,21280,16640,38870,15981,42070,32499,46040,11070
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,2. Stocks Received,402910,64500,19060,22000,24500,21490,71500,22000,22170,43500,43000,49190
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,3. Unusable Stock,12870,0,0,0,0,0,12870,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,4. Stock Distributed,373275,49240,20150,23680,20900,20490,65750,24530,18440,39255,41110,49730
M16 [Stock Position (During the month)],16.1.3,Stock position of TT vaccines,5. Total Stock,346045,69600,9420,38300,24880,17640,31750,13451,45800,36744,47930,10530
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,2820,0,0,NA,2820,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,2. Stocks Received,6300,0,0,NA,6300,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,4. Stock Distributed,4010,0,0,NA,4010,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.4,Stock position of DT vaccines,5. Total Stock,5110,0,0,0,5110,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,250910,11100,13130,27880,19020,13660,34740,14040,53300,35150,11640,17250
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,2. Stocks Received,274610,28500,12000,47000,16000,16000,49500,25350,13260,20000,10000,37000
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,3. Unusable Stock,16790,1620,0,0,0,0,15170,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,4. Stock Distributed,263780,27530,14240,40790,14350,14440,47450,26330,13600,21290,10240,33520
M16 [Stock Position (During the month)],16.1.5,Stock position of BCG vaccines,5. Total Stock,244950,10450,10890,34090,20670,15220,21620,13060,52960,33860,11400,20730
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,249075,17920,12625,29970,13775,16800,20725,10940,38995,28190,28825,30310
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,2. Stocks Received,258050,25500,18190,12800,21500,19250,43000,20470,15840,28000,18000,35500
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,3. Unusable Stock,12500,1600,0,0,0,0,10900,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,4. Stock Distributed,245825,23160,19250,13035,18990,18525,42285,21595,15910,27660,16220,29195
M16 [Stock Position (During the month)],16.1.6,Stock position of Measles vaccines,5. Total Stock,248800,18660,11565,29735,16285,17525,10540,9815,38925,28530,30605,36615
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,122890,7090,13180,20200,7080,5360,19400,14580,7470,7490,9460,11580
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,121950,17210,2990,26000,4000,2500,25840,18730,3180,3500,4500,13500
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,7460,280,0,0,0,0,7180,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,114230,16740,5260,22330,2850,2070,18980,18970,3940,4760,4940,13390
M16 [Stock Position (During the month)],16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,123150,7280,10910,23870,8230,5790,19080,14340,6710,6230,9020,11690
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,45034,4767,2174,1984,8170,4284,3421,4830,2764,4485,5645,2510
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,24383,1800,1433,1400,3600,1150,4200,2600,1800,1800,1600,3000
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,1114,219,0,0,0,0,895,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,31197,1766,1411,913,2406,2723,2502,11525,1357,1530,1655,3409
M16 [Stock Position (During the month)],16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,37106,4582,2196,2471,9364,2711,4224,-4095,3207,4755,5590,2101
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,3099230,64120,27780,270620,164730,111920,2135400,32720,205200,64800,21940,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,1724610,117360,49300,129600,139630,43200,689400,70620,238000,247500,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,983640,8640,0,0,0,0,975000,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,1691530,96340,41940,43020,127470,94350,733200,72340,221800,242100,18970,NA
M16 [Stock Position (During the month)],16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,2148670,76500,35140,357200,176890,60770,1116600,31000,221400,70200,2970,0
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,148656,7956,6658,11040,25125,10240,11027,10000,17450,18630,16885,13645
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,78121,9500,4471,6500,11200,3000,8000,6950,8000,9000,4500,7000
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,7013,3231,0,0,0,0,3782,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,70823,7794,4344,4390,8410,3920,9055,7550,7500,8730,4295,4835
M16 [Stock Position (During the month)],16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,148941,6431,6785,13150,27915,9320,6190,9400,17950,18900,17090,15810
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,57355,1626,6065,2378,10850,2620,14364,6300,2620,1865,5860,2807
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,12330,600,3225,600,1800,500,0,2000,1320,885,700,700
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,7171,61,0,0,0,0,7110,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,10852,501,1915,202,890,449,2322,2500,670,385,415,603
M16 [Stock Position (During the month)],16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,51662,1664,7375,2776,11760,2671,4932,5800,3270,2365,6145,2904
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,2034,NA,0,100,0,0,664,120,350,0,600,200
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,3800,NA,0,1000,0,0,1000,300,300,0,700,500
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,664,NA,0,0,0,0,664,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,2700,NA,0,900,0,0,500,300,200,0,300,500
M16 [Stock Position (During the month)],16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2470,0,0,200,0,0,500,120,450,0,1000,200
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,2,NA,0,NA,0,2,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,-2,0,0,0,0,-2,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1124050,135750,0,263850,167800,37000,415200,52100,NA,NA,52350,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,2. Stocks Received,895000,90000,0,270000,300000,120000,10000,105000,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,30000,NA,0,0,0,0,30000,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,797400,142600,0,125950,234800,45500,120600,105000,NA,NA,22950,NA
M16 [Stock Position (During the month)],16.3.07,Stock Position of IFA Tablets,5. Total Stock,1191650,83150,0,407900,233000,111500,274600,52100,0,0,29400,0
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,63000,NA,0,NA,0,63000,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,39500,NA,0,NA,0,39500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,46500,NA,0,NA,0,46500,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,56000,0,0,0,0,56000,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,NA,0,NA,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,11472,NA,772,310,561,1112,5455,472,946,477,1308,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,7628,NA,800,550,800,493,2160,855,650,770,550,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,148,NA,0,0,0,0,148,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,6870,NA,1095,394,642,1215,772,742,473,718,760,59
M16 [Stock Position (During the month)],16.3.10,Stock Position of Vitamin A solution,5. Total Stock,12082,0,477,466,719,390,6695,585,1123,529,1098,0
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,72820,NA,0,14300,8200,25800,3800,14700,NA,NA,6020,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,112400,NA,0,11600,43800,15200,41600,200,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,NA,0,0,0,0,NA,NA,NA,NA,0,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,108510,NA,0,11450,35800,10600,41400,5700,NA,NA,3560,NA
M16 [Stock Position (During the month)],16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,76710,0,0,14450,16200,30400,4000,9200,0,0,2460,0
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,256394,14010,17571,30465,13800,15466,37200,12050,53450,28600,18122,15660
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,198547,19000,12945,44000,16000,4462,33000,17250,11090,16000,6000,18800
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,19000,800,0,0,0,0,18200,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,173191,15890,12111,30270,15450,6550,28000,18450,6000,12300,6930,21240
M16 [Stock Position (During the month)],16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,262750,16320,18405,44195,14350,13378,24000,10850,58540,32300,17192,13220
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2536020,255800,24220,114700,520790,86000,156200,59800,519800,378500,167350,252860
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,1567750,161800,93500,60800,216000,93600,247200,96150,126500,139600,131800,200800
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,205000,101700,0,0,0,0,103300,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,1504540,168900,95990,66100,143400,96500,238800,98700,92200,178300,127250,198400
M16 [Stock Position (During the month)],16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,2394230,147000,21730,109400,593390,83100,61300,57250,554100,339800,171900,255260
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,322233,44690,15050,7575,14850,12475,39500,14200,66180,68000,19873,19840
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,120925,13000,16500,3000,9000,2995,18500,14400,10530,8000,8500,16500
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,31700,12600,0,0,0,0,19100,NA,0,0,0,NA
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,108428,8970,10920,2280,10050,3600,18700,11900,5400,12100,10483,14025
M16 [Stock Position (During the month)],16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,303030,36120,20630,8295,13800,11870,20200,16700,71310,63900,17890,22315
M17 [Details of deaths reported during the month with probable causes:],17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,105,18,1,10,4,8,58,1,1,1,1,2
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,369,51,155,119,3,1,22,1,3,NA,3,11
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,95,8,27,35,5,NA,19,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,464,59,182,154,8,1,41,1,3,NA,3,12
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,241,34,58,107,8,NA,25,2,4,NA,2,1
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,12,1,2,6,NA,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,253,35,60,113,8,NA,27,2,4,NA,2,2
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,361,43,4,108,4,4,36,NA,3,1,2,156
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,17,4,NA,4,NA,NA,8,1,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,378,47,4,112,4,4,44,1,3,1,2,156
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,462,35,82,125,8,8,112,4,2,6,8,72
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,40,4,12,7,2,3,12,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,502,39,94,132,10,11,124,4,2,6,8,72
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,140,10,31,74,6,NA,12,1,2,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,68,2,15,42,1,NA,5,2,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,208,12,46,116,7,NA,17,3,2,NA,NA,5
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,37,1,NA,24,1,1,7,1,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,13,NA,NA,11,NA,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,50,1,NA,35,1,1,8,1,NA,NA,NA,3
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,42,NA,NA,36,NA,2,1,NA,NA,NA,2,1
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,41,NA,NA,36,1,NA,1,NA,1,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,83,NA,NA,72,1,2,2,NA,1,NA,2,3
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,350,17,70,170,10,5,49,9,8,NA,3,9
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,156,8,29,74,4,2,15,4,2,NA,1,17
M17 [Details of deaths reported during the month with probable causes:],17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,506,25,99,244,14,7,64,13,10,NA,4,26
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,8,NA,NA,6,NA,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,104,26,2,52,1,NA,14,1,NA,NA,2,6
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,60,11,1,19,NA,NA,23,1,NA,NA,NA,5
M17 [Details of deaths reported during the month with probable causes:],17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,172,37,3,77,1,NA,38,2,NA,NA,2,12
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,20,NA,NA,12,NA,NA,6,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,280,16,12,101,3,NA,88,10,1,1,NA,48
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,194,15,7,94,3,NA,37,6,NA,2,6,24
M17 [Details of deaths reported during the month with probable causes:],17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,494,31,19,207,6,NA,131,16,1,3,6,74
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,58,2,4,42,2,NA,2,2,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,491,59,33,150,14,NA,116,15,5,10,8,81
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,808,123,96,126,27,NA,212,26,4,18,28,148
M17 [Details of deaths reported during the month with probable causes:],17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,1357,184,133,318,43,NA,330,43,9,28,36,233
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,1,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,11,NA,1,2,NA,NA,6,NA,1,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,13,NA,1,3,NA,NA,7,NA,1,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,74,2,NA,55,1,NA,11,1,1,1,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,261,37,6,44,11,NA,111,1,NA,1,2,48
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,171,44,5,15,6,NA,73,1,NA,4,1,22
M17 [Details of deaths reported during the month with probable causes:],17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,506,83,11,114,18,NA,195,3,1,6,3,72
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,49,3,1,7,NA,NA,19,1,NA,NA,NA,18
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,5,NA,NA,2,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,54,3,1,9,NA,NA,22,1,NA,NA,NA,18
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,21,1,2,5,1,NA,8,1,1,NA,1,1
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,679,69,49,200,33,NA,142,27,12,6,31,110
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,1299,179,97,347,35,NA,235,33,56,22,51,244
M17 [Details of deaths reported during the month with probable causes:],17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,1999,249,148,552,69,NA,385,61,69,28,83,355
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,21,1,NA,13,1,NA,6,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,248,32,12,31,5,NA,106,21,NA,NA,3,38
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,232,32,42,15,2,NA,96,8,1,NA,11,25
M17 [Details of deaths reported during the month with probable causes:],17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,501,65,54,59,8,NA,208,29,1,NA,14,63
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,3,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,3,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,34,5,NA,20,NA,NA,5,NA,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,34,5,NA,20,NA,NA,5,NA,NA,NA,NA,4
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,24,6,NA,6,NA,NA,8,NA,NA,NA,1,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,24,6,NA,6,NA,NA,8,NA,NA,NA,1,3
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,20,2,1,14,NA,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,20,2,1,14,NA,NA,2,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,184,20,2,50,4,1,13,61,2,NA,2,29
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,184,20,2,50,4,1,13,61,2,NA,2,29
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,16,NA,2,11,1,NA,1,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,617,18,52,296,75,NA,85,3,NA,NA,7,81
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,134,8,21,39,8,NA,27,1,1,NA,4,25
M17 [Details of deaths reported during the month with probable causes:],17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,767,26,75,346,84,NA,113,4,1,NA,11,107
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,2,2,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,47,NA,NA,2,13,NA,19,1,NA,NA,10,2
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,8,1,2,1,1,NA,2,NA,NA,NA,1,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,57,3,2,3,14,NA,21,1,NA,NA,11,2
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,10,NA,NA,1,3,NA,3,NA,NA,NA,1,2
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
M17 [Details of deaths reported during the month with probable causes:],17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,13,1,NA,1,4,NA,3,NA,NA,NA,1,3
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,132,10,64,53,NA,NA,3,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1279,142,3,930,11,NA,101,4,NA,NA,3,85
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,908,190,3,579,5,NA,70,7,NA,NA,3,51
M17 [Details of deaths reported during the month with probable causes:],17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,2319,342,70,1562,16,NA,174,11,NA,NA,6,138
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,50,5,8,31,NA,NA,4,NA,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,1041,133,34,440,10,NA,221,23,NA,NA,8,172
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1049,192,55,310,10,NA,264,40,1,1,24,152
M17 [Details of deaths reported during the month with probable causes:],17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,2140,330,97,781,20,NA,489,63,1,1,32,326
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,21,NA,13,1,1,NA,1,3,NA,NA,NA,2
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,805,21,286,96,68,NA,178,77,2,9,10,58
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,557,8,165,43,11,NA,160,88,17,14,39,12
M17 [Details of deaths reported during the month with probable causes:],17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,1383,29,464,140,80,NA,339,168,19,23,49,72
